← See all members

Francis Beaudry

Ph.D. (doctor),  Regular member
Expertise
Pharmacology
Principal Interest
Rx (cannabis, opioids, ionic channels)
Secondary Interest
Neuropathic pain
Primary Affiliation

Université de Montréal

Secondary Affiliation
Center for Interdisciplinary Research on Brain and Learning
Visit the website
Publications

Biography

Professor Francis Beaudry is a Professor of Analytical Pharmacology at the Faculty of Veterinary Medicine at the Université de Montréal and holds a Tier 1 Canada Research Chair in Bioactive Molecule Metrology and Target Discovery. Trained as a chemist, his expertise is widely recognized in mass spectrometry, proteomics, metabolomics, and analytical pharmacology.
His research focuses on the molecular mechanisms of nociception, the identification of novel therapeutic targets, and the development of innovative approaches for the study of bioactive molecules. His program integrates experimental models ranging from Caenorhabditis elegans to preclinical models of pain and neurological diseases.
Author of more than 180 peer-reviewed scientific publications, he supervises numerous graduate students and postdoctoral fellows. He is also a researcher affiliated with the Centre for Interdisciplinary Research on the Brain and Learning (CIRCA), the Quebec Pain Research Network (QPRN), and the Quebec Network for Drug Research (RQRM).

Why did you choose this career?
From my early teens, I developed a deep passion for the sciences, particularly physics, chemistry, and mathematics. This curiosity naturally led me toward an academic career, where I can both share this knowledge and contribute to the advancement of science. For me, becoming a university professor represents a unique opportunity to train the next generation of scientists while pursuing fundamental scientific questions. My research program builds on this foundation by integrating molecular modeling, medicinal and analytical chemistry, and mass spectrometry. This combination of approaches allows me to tackle pain from an innovative angle, aiming to develop new therapeutic strategies that can improve patients’ quality of life.